12 December 2024. More on this story... Pfizer's rollercoaster ride and what comes next · Biotechnology.
News
- Ibrance combination extends median PFS in breast cancer group | The Pharmaletter
- TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin ... - BioSpace
These data were presented in a poster session at the 2024 San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio, TX.1 A copy of ...
- Holland & Knight Expands Intellectual Property Group with Addition of Partner Kenneth ...
His practice covers various industries, including biotech ... degree in physiology from The University of Texas Health Science Center at San Antonio and ...
- Trial finds quality of life similar among patients with low-risk DCIS whether they received ...
Biomedical technology · Cardiology · Dentistry ... San Antonio Breast Cancer Symposium (SABCS) ... Medical Xpress is a web-based medical and health news ...
- Stirista Climbs to #4 on San Antonio Business Journal's 2024 Fast Track Awards
Biotechnology · Clinical Trials & Medical Discoveries · Dentistry · FDA ... San Antonio Business Journal's Fast Track Awards for 2024. This marks ...